Cargando…

PSUN303 Nationwide Geospatial Analysis of Hospitalization in Diabetes Mellitus Complications

Diabetes mellitus and complications associated with the disease represent a significant source of morbidity within the United States. Substantial public health efforts have been devoted to understanding the factors that underlie poor outcomes in diabetes. The purpose of this work is to (1) determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Claire, Lowe, Jacques, Peterman, Nicholas, Kaptur, Bradley, Yeo, Eunhae, Carpenter, Kristine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625758/
http://dx.doi.org/10.1210/jendso/bvac150.849
_version_ 1784822581053882368
author Lee, Claire
Lowe, Jacques
Peterman, Nicholas
Kaptur, Bradley
Yeo, Eunhae
Carpenter, Kristine
author_facet Lee, Claire
Lowe, Jacques
Peterman, Nicholas
Kaptur, Bradley
Yeo, Eunhae
Carpenter, Kristine
author_sort Lee, Claire
collection PubMed
description Diabetes mellitus and complications associated with the disease represent a significant source of morbidity within the United States. Substantial public health efforts have been devoted to understanding the factors that underlie poor outcomes in diabetes. The purpose of this work is to (1) determine whether there exist statistically significant geospatial disparities in the relative rate of diabetic complications in Medicare patients throughout the United States, and (2) if these exist, assess the socioeconomic, cultural, and medical attributes that distinguish communities delineated by these variations. This work utilized multiple public databases, including National Plan and Provider Enumeration System (NPPES), US Department of Agriculture (USDA), US Census, and Center for Medicare Services (CMS) data. Datasets were combined on a county level to quantify 18 socioeconomic, 22 health, and 4 diabetic management attributes of 3061 total counties in the contiguous United States. CMS Prevention Quality Indicators (PQI) #1 (Diabetes Short-Term Complications Admission Rate), #3 (Diabetes Long-Term Complications Admission Rate), and #16 (Lower-Extremity Amputation Among Patients with Diabetes Rate) were used as the main indicators of county-level diabetic control, along with the total number of practicing endocrinologists. These variables were scaled to the number of Medicare members with diabetes in each county. All variables were for the latest available year, 2019, with the exception of the number of practicing endocrinologists (from December 2021). The synthesized database was then exported to GeoDa, a geospatial analysis program, where statistically significant (p < 0.05) diabetes complication spatial hotspots, coldspots, and outliers were identified using Moran's I on a national level. ANOVA was then conducted across all Moran's I groupings with a two-tailed t-test between hotspot and coldspot groupings to identify what socioeconomic, health, and diabetic management attributes were statistically significant between complication geostructures. Geospatial visualization revealed an expansive hotspot cluster in the normalized diabetes long-term complication admission rate that encompassed the East Coast and included portions of Florida and Texas (p < 0.05). Conversely, an expansive coldspot cluster encompassed much of the West and Great Plains region. Similar geospatial patterns were observed in the short-term complication admission rate, with the caveat of a new hotspot cluster that encompassed California and the West Coast (p < 0.05). ANOVA using the identified clusters as groupings revealed differences between hotspot and coldspot clusters: Hotspots tended to have greater Hispanic (6.7% to 1.8%) and Black (10.9% to 0.6%) representation compared to coldspots. They tended to have greater population density (2877 to 124 persons/sq. mile). Hotspots also tended to have more endocrinologists per capita (3.0 to 0.87) than coldspots. Variables of interest that did not appear to differ included the percent in poverty and the percent uninsured. Presentation: Sunday, June 12, 2022 12:30 p.m. - 2:30 p.m.
format Online
Article
Text
id pubmed-9625758
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96257582022-11-14 PSUN303 Nationwide Geospatial Analysis of Hospitalization in Diabetes Mellitus Complications Lee, Claire Lowe, Jacques Peterman, Nicholas Kaptur, Bradley Yeo, Eunhae Carpenter, Kristine J Endocr Soc Diabetes & Glucose Metabolism Diabetes mellitus and complications associated with the disease represent a significant source of morbidity within the United States. Substantial public health efforts have been devoted to understanding the factors that underlie poor outcomes in diabetes. The purpose of this work is to (1) determine whether there exist statistically significant geospatial disparities in the relative rate of diabetic complications in Medicare patients throughout the United States, and (2) if these exist, assess the socioeconomic, cultural, and medical attributes that distinguish communities delineated by these variations. This work utilized multiple public databases, including National Plan and Provider Enumeration System (NPPES), US Department of Agriculture (USDA), US Census, and Center for Medicare Services (CMS) data. Datasets were combined on a county level to quantify 18 socioeconomic, 22 health, and 4 diabetic management attributes of 3061 total counties in the contiguous United States. CMS Prevention Quality Indicators (PQI) #1 (Diabetes Short-Term Complications Admission Rate), #3 (Diabetes Long-Term Complications Admission Rate), and #16 (Lower-Extremity Amputation Among Patients with Diabetes Rate) were used as the main indicators of county-level diabetic control, along with the total number of practicing endocrinologists. These variables were scaled to the number of Medicare members with diabetes in each county. All variables were for the latest available year, 2019, with the exception of the number of practicing endocrinologists (from December 2021). The synthesized database was then exported to GeoDa, a geospatial analysis program, where statistically significant (p < 0.05) diabetes complication spatial hotspots, coldspots, and outliers were identified using Moran's I on a national level. ANOVA was then conducted across all Moran's I groupings with a two-tailed t-test between hotspot and coldspot groupings to identify what socioeconomic, health, and diabetic management attributes were statistically significant between complication geostructures. Geospatial visualization revealed an expansive hotspot cluster in the normalized diabetes long-term complication admission rate that encompassed the East Coast and included portions of Florida and Texas (p < 0.05). Conversely, an expansive coldspot cluster encompassed much of the West and Great Plains region. Similar geospatial patterns were observed in the short-term complication admission rate, with the caveat of a new hotspot cluster that encompassed California and the West Coast (p < 0.05). ANOVA using the identified clusters as groupings revealed differences between hotspot and coldspot clusters: Hotspots tended to have greater Hispanic (6.7% to 1.8%) and Black (10.9% to 0.6%) representation compared to coldspots. They tended to have greater population density (2877 to 124 persons/sq. mile). Hotspots also tended to have more endocrinologists per capita (3.0 to 0.87) than coldspots. Variables of interest that did not appear to differ included the percent in poverty and the percent uninsured. Presentation: Sunday, June 12, 2022 12:30 p.m. - 2:30 p.m. Oxford University Press 2022-11-01 /pmc/articles/PMC9625758/ http://dx.doi.org/10.1210/jendso/bvac150.849 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Diabetes & Glucose Metabolism
Lee, Claire
Lowe, Jacques
Peterman, Nicholas
Kaptur, Bradley
Yeo, Eunhae
Carpenter, Kristine
PSUN303 Nationwide Geospatial Analysis of Hospitalization in Diabetes Mellitus Complications
title PSUN303 Nationwide Geospatial Analysis of Hospitalization in Diabetes Mellitus Complications
title_full PSUN303 Nationwide Geospatial Analysis of Hospitalization in Diabetes Mellitus Complications
title_fullStr PSUN303 Nationwide Geospatial Analysis of Hospitalization in Diabetes Mellitus Complications
title_full_unstemmed PSUN303 Nationwide Geospatial Analysis of Hospitalization in Diabetes Mellitus Complications
title_short PSUN303 Nationwide Geospatial Analysis of Hospitalization in Diabetes Mellitus Complications
title_sort psun303 nationwide geospatial analysis of hospitalization in diabetes mellitus complications
topic Diabetes & Glucose Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625758/
http://dx.doi.org/10.1210/jendso/bvac150.849
work_keys_str_mv AT leeclaire psun303nationwidegeospatialanalysisofhospitalizationindiabetesmellituscomplications
AT lowejacques psun303nationwidegeospatialanalysisofhospitalizationindiabetesmellituscomplications
AT petermannicholas psun303nationwidegeospatialanalysisofhospitalizationindiabetesmellituscomplications
AT kapturbradley psun303nationwidegeospatialanalysisofhospitalizationindiabetesmellituscomplications
AT yeoeunhae psun303nationwidegeospatialanalysisofhospitalizationindiabetesmellituscomplications
AT carpenterkristine psun303nationwidegeospatialanalysisofhospitalizationindiabetesmellituscomplications